Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

3 terminated/withdrawn out of 6 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

2(50.0%)

N/A

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 4(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01997242Completed

The Surgery After Stenting (SAS) Registry

Role: collaborator

NCT01023438Not ApplicableTerminated

Strategies to Improve Prescribing in Heart Failure Patients

Role: collaborator

NCT01140399Phase 4Terminated

REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure

Role: collaborator

NCT00700856Phase 4Unknown

Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial

Role: collaborator

NCT01216462Unknown

Registry of Acute Coronary Syndromes in the Lazio Region of Italy

Role: collaborator

NCT01187992Phase 3Terminated

Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease

Role: collaborator

All 6 trials loaded